Home | Welcome to Contract Pharma   
Last Updated Friday, May 29 2015

Print RSS Feed

Search Results for 'Financial Report: Johnson'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 18, 2015
Pharma sales down 7% in the quarter Read More »
Published January 20, 2015
Pharmaceutical sales up 15% for the year Read More »
Published October 14, 2014
Pharmaceutical sales up 18% in the quarter, new products drive growth Read More »
Published July 15, 2014
Revenues up 9% in the quarter driven by new products Read More »
Published April 16, 2014
Revenues up 3% in the quarter Read More »
By Kristin Brooks
Published January 21, 2014
Pharma sales drive growth Read More »
Published October 15, 2013
Pharmaceutical sales up 10% in the quarter Read More »
Published July 16, 2013
Revenues up 9% in the quarter Read More »
Published April 16, 2013
Revenues up 9% in the quarter Read More »
Published January 22, 2013
Revenues up 8% in the quarter Read More »
Published July 18, 2012
Earnings drop 49% in the quarter Read More »
Published January 24, 2012
FY Earnings hit by after-tax charges of $4.2 billion Read More »
Published October 18, 2011
Pharmaceutical sales up 9% Read More »
Published April 19, 2011
Worldwide Pharmaceutical sales were $6.1 billion in the quarter. Read More »
Published October 19, 2010
Worldwide Pharmaceutical sales were $5.5 billion in the quarter (+5%), with operational growth of 6% and a negative impact from currency of 1%. Read More »
Published January 26, 2010
Worldwide Pharmaceutical sales were $22.5 billion for the year (-8%), while Worldwide Medical Devices and Diagnostics sales were $23.6 billion for year (+2%). Read More »
Published July 14, 2009
Worldwide pharmaceutical sales were $5.5 billion in the quarter (-13%), including a 5% negative impact from currency. Read More »
Published April 14, 2009
Worldwide pharmaceutical sales were $5.8 billion in the quarter (-10%) with an operational decline of 5% and a negative impact from currency of 5%. Domestic sales were down 10%. Read More »
Published January 20, 2009
Johnson & Johnson 4Q Revenues: $15.2 billion (-5%) 4Q Earnings: $2.7 billion (+13%) FY Revenues: $63.7 billion (+4%) FY Earnings: $12.9 billion (+22%) Comments: Pharmaceutical sales were $5.7 billion in the quarter (-11%) and $24.6… Read More »
Published October 14, 2008
Johnson & Johnson 3Q Revenues: $15.9 billion (+3%) 3Q Earnings: $3.3 billion (+30%) YTD Revenues: $48.6 billion (+8%) YTD Earnings: $10.2 billion (+25%) Comments: Worldwide Pharmaceutical sales were flat at $6.1 billion in the qua… Read More »
Published July 15, 2008
Johnson & Johnson 2Q Revenues: $16.5 billion (+9%) 2Q Earnings: $3.3 billion (+8%) YTD Revenues: $32.6 billion (+8%) YTD Earnings: $6.9 billion (+23%) Comments: Pharmaceutical sales were $6.3 billion (+3%), driven by Topamax sales ($677… Read More »
Published October 16, 2007
Johnson & Johnson   3Q Revenues: $15 billion (+13%) 3Q Earnings: $2.5 billion (-8%) YTD Revenues: $45.1 billion (+14%) YTD Earnings: $8.2 billion (-8%) Comments: Worldwide pharmaceutical sales were $6.1 billion in the quarter,… Read More »
Published July 17, 2007
Johnson & Johnson 2Q Revenues: $15.1 billion (+13%) 2Q Earnings: $3.1 billion (+9%) YTD Revenues: $30.2 billion (+15%) YTD Earnings: $5.7 billion (-8%) Comments: Worldwide Pharmaceutical sales were $6.1 billion in the quarter,… Read More »
Published April 17, 2007
Johnson & Johnson 1Q Revenues: $15 billion (+16%) 1Q Earnings: $2.6 billion (-22%) Comments: Worldwide Pharmaceutical sales were $6.2 billion in the quarter, up 11%. Sales growth reflects the strong performance of Topamax, Levaquin,… Read More »
Published January 23, 2007
Johnson & Johnson 4Q Revenues: $13.7 billion (+8.5%) 4Q Earnings: $2.2 billion (+3.5%) FY Revenues: $53.3 billion (+5.6%) FY Earnings: $11 billion (+10%) Comments: Worldwide pharmaceutical sales were $23.3 billion for the year… Read More »
Published July 18, 2006
Johnson & Johnson   2Q Revenues: $13.4 billion (+5%) 2Q Earnings: $2.8 billion (+7%) YTD Revenues: $26.4 billion (+3%) YTD Earnings: $6.1 billion (+13%) Comments: Worldwide pharmaceutical sales were $5.8 billion for the qu… Read More »
Published April 18, 2006
Johnson & Johnson 1Q Revenues: $13 billion (+1.2%) 1Q Earnings: $3.3 billion* (+4.5%) Comments: Worldwide Pharmaceutical sales were $5.6 billion for the quarter, down 2.2%. Sales results for Duragesic, Ultracet, and Sporanox, were a… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On